Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Kieran A Gallagher"'
Autor:
Vivienne M. Hazzard, Belinda L. Needham, Kendrin R. Sonneville, Kieran A Gallagher, Traci L. Carson
Publikováno v:
Eating Disorders. 29:29-41
Due to stigma, eating disorders are under-researched, underdiagnosed and undertreated among men. This is particularly pertinent among athletes, as athletic goals are a major risk factor for disordered eating in men. This gender stereotype may be rein
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d808580bdfcef71e07c51bd44ed04f05
https://doi.org/10.1080/10640266.2019.1613846
https://doi.org/10.1080/10640266.2019.1613846
Autor:
Peter O'Connell, Zelalem Ayenew Worku, Yunliang He, Åke C. Rasmuson, Brian Glennon, Kiran A. Ramisetty, João Victor Teixeira Gomes, Dinesh Kumar, Anne Marie Healy, Nalini R. Shastri, Kieran H. Gallagher, Trevor Woods
Publikováno v:
International Journal of Pharmaceutics. 531:191-204
peer-reviewed The development of solid dosage forms and manufacturing processes are governed by complex physical properties of the powder and the type of pharmaceutical unit operation the manufacturing processes employs. Suitable powder flow properti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bd07a2a35d9bb77a68f9f08c1f54c884
https://doi.org/10.1016/j.ijpharm.2017.08.063
https://doi.org/10.1016/j.ijpharm.2017.08.063
Autor:
Youness Amharar, Vincent Curtin, Anne Marie Healy, Peter O'Connell, Eoin O'Siochru, Kieran H. Gallagher
Publikováno v:
European Journal of Pharmaceutical Sciences. 81:181-188
Co-processing an active pharmaceutical ingredient (API) with a low Tg excipient has been previously reported to be an effective strategy for preventing drug amorphisation on milling. This technique relies on the ability of the excipient to form a mol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::732119eeed2d7b3cf3a1828a13500c07
https://doi.org/10.1016/j.ejps.2015.10.016
https://doi.org/10.1016/j.ejps.2015.10.016
Publikováno v:
Current Topics in Medicinal Chemistry. 15:2327-2340
The overall pharmaceutical market is changing. A more personalised medicine approach is replacing the concept of blockbuster drugs and the "one size fits all" model. The two main forces that fuel the growth of nano-enabled drug technologies are the l
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fb6bcde8c3adb0798862d93f732055e5
https://doi.org/10.2174/1568026615666150605122917
https://doi.org/10.2174/1568026615666150605122917
Publikováno v:
International Journal of Pharmaceutics. 472:241-247
Pharmaceutical applications which require knowledge of the solubility of a crystalline compound in an amorphous matrix are abundant in the literature. Several methods that allow the determination of such data have been reported, but so far have only
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7e38cea821d6452baa823f2b5a7d80db
https://doi.org/10.1016/j.ijpharm.2014.06.038
https://doi.org/10.1016/j.ijpharm.2014.06.038
Autor:
Youness Amharar, Lidia Tajber, Anne Marie Healy, Vincent Curtin, Kieran H. Gallagher, Sarah E. Corcoran, Owen I. Corrigan
Publikováno v:
International journal of pharmaceutics. 456(2)
The unintentional generation of amorphous character in crystalline active pharmaceutical ingredients (APIs) is an adverse consequence of mechanical activation during dosage form manufacture. In this study, we assess and compare the ability of low gla
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1e5c54d7c0ad1ed3b0abaad4ea557b13
https://pubmed.ncbi.nlm.nih.gov/23994365
https://pubmed.ncbi.nlm.nih.gov/23994365